Taiwan - Delayed Quote TWD
All Cosmos Bio-Tech Holding Corporation (4148.TW)
47.00
-0.20
(-0.42%)
As of 12:35:35 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,458,636
2,458,636
2,826,587
3,702,330
2,197,323
Cost of Revenue
1,790,045
1,790,045
2,238,608
2,564,754
1,602,958
Gross Profit
668,591
668,591
587,979
1,137,576
594,365
Operating Expense
504,879
504,879
400,083
477,845
381,630
Operating Income
163,712
163,712
187,896
659,731
212,735
Net Non Operating Interest Income Expense
29,151
29,151
26,434
-7,323
4,895
Pretax Income
252,770
252,770
257,630
633,950
321,585
Tax Provision
78,280
78,280
68,321
177,931
84,931
Net Income Common Stockholders
128,588
128,588
139,361
368,204
198,128
Diluted NI Available to Com Stockholders
128,588
128,588
139,361
368,204
198,128
Basic EPS
2.01
--
2.18
5.75
3.09
Diluted EPS
1.94
--
2.13
5.65
3.09
Basic Average Shares
63,974.13
--
63,927.06
64,034
64,034
Diluted Average Shares
66,282.47
--
65,427.70
66,041
64,207
Total Expenses
2,294,924
2,294,924
2,638,691
3,042,599
1,984,588
Net Income from Continuing & Discontinued Operation
128,588
128,588
139,361
368,204
198,128
Normalized Income
133,996.59
133,996.59
137,892.12
362,980.95
153,601.71
Interest Income
35,234
35,234
30,417
11,487
9,432
Interest Expense
6,083
6,083
3,983
18,810
4,537
Net Interest Income
29,151
29,151
26,434
-7,323
4,895
EBIT
258,853
258,853
261,613
652,760
326,122
EBITDA
312,832
312,832
310,760
701,772
374,714
Reconciled Cost of Revenue
1,790,045
1,790,045
2,238,608
2,564,754
1,602,958
Reconciled Depreciation
53,979
53,979
49,147
49,012
48,592
Net Income from Continuing Operation Net Minority Interest
128,588
128,588
139,361
368,204
198,128
Total Unusual Items Excluding Goodwill
-7,835
-7,835
1,999
7,261
60,506
Total Unusual Items
-7,835
-7,835
1,999
7,261
60,506
Normalized EBITDA
320,667
320,667
308,761
694,511
314,208
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,426.41
-2,426.41
530.12
2,037.95
15,979.71
12/31/2021 - 6/9/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade